Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Use of Drugs and Constipation in Nursing Homes

This study has been completed.
Sykehuset Innlandet HF
Information provided by (Responsible Party):
Norwegian University of Science and Technology Identifier:
First received: February 23, 2009
Last updated: July 18, 2016
Last verified: July 2016
The purpose of this study is to study factors (drugs, serum concentration of drugs, nutrition, physical activity, demographics, diseases etc.) related to constipation and diarrhea in nursing homes, and the effect of different laxative regimens.


Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Use of Drugs and Constipation in Nursing Homes

Resource links provided by NLM:

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • Prevalence of constipation [ Time Frame: One year ] [ Designated as safety issue: No ]

Enrollment: 267
Study Start Date: June 2008
Study Completion Date: February 2010
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)


Ages Eligible for Study:   60 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Residents in nursing homes

Inclusion Criteria:

  • Above 60 years old
  • Stayed in nursing homes for more than 8 weeks
  • Informed consent

Exclusion Criteria:

  • Expected discharge within 2 weeks
  • Organic disorders causing constipation and diarrhea
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00849628

Innlandet Hospital Trust
Gjøvik, Oppland, Norway, 2819
Sponsors and Collaborators
Norwegian University of Science and Technology
Sykehuset Innlandet HF
Principal Investigator: Per G Farup, PhD Sykehuset Innlandet HF
  More Information

Responsible Party: Norwegian University of Science and Technology Identifier: NCT00849628     History of Changes
Other Study ID Numbers: SI 150069-1 
Study First Received: February 23, 2009
Last Updated: July 18, 2016
Health Authority: Norway: Data Protection Authority
Croatia: Ministry of Health and Social Care
Norway: Directorate of Health
Norway:National Committee for Medical and Health Research Ethics

Keywords provided by Norwegian University of Science and Technology:
Adverse effects
Nursing homes

Additional relevant MeSH terms:
Signs and Symptoms, Digestive
Signs and Symptoms processed this record on December 09, 2016